Health and Medical Economics Applied to Integrative Medicine

Kenneth R Pelletier, Patricia M. Herman, R. Douglas Metz, Craig F. Nelson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Cost-benefit analyses (CBA) of every aspect of health and medical care are a necessity to address both the clinical effectiveness and cost effectiveness of health and medical care for the purpose of allocating limited practitioner, organizational, governmental, and monetary resources while maintaining the highest quality outcomes. In response, there are an array of approaches that emphasize the full continuum of prevention, restructuring primary care, involvement of the workplace and communities, and adoption of innovative strategies and interventions ranging from genomic assessments to complementary and alternative medicine (CAM). Among these approaches is an integrative medicine (IM) model that is consistent with these national objectives and that uniquely and explicitly includes "evidence-based global medical strategies" in its definition. All of these strategies require rigorous, appropriate, state-of-the art medical economic analyses. Since few if any IM models have been rigorously evaluated in terms of CBA, it is possible to draw upon the cost-effectiveness research focused on a limited number of CAM modalities as well as from the work-site/corporate clinical and cost outcomes research to suggest the evidence-based foundation from which a true healthcare system will evolve.

Original languageEnglish (US)
Pages (from-to)86-99
Number of pages14
JournalExplore: The Journal of Science and Healing
Volume6
Issue number2
DOIs
StatePublished - Mar 2010

Fingerprint

Integrative Medicine
Medical Economics
Complementary Therapies
Medicine
Cost-Benefit Analysis
Health
Economics
Cost-effectiveness
Delivery of Health Care
Workplace
Costs
Primary Care
Alternatives
Modality
Healthcare
Genomics
Primary Health Care
Continuum
Outcome Assessment (Health Care)
Costs and Cost Analysis

Keywords

  • clinical outcomes
  • complementary and alternative medicine
  • cost outcomes
  • evidence based
  • Integrative medicine
  • medical economics
  • Patient Centered Medical Home (PCMH)
  • prevention
  • primary care

ASJC Scopus subject areas

  • Complementary and alternative medicine
  • Chiropractics
  • Analysis
  • Nursing(all)

Cite this

Health and Medical Economics Applied to Integrative Medicine. / Pelletier, Kenneth R; Herman, Patricia M.; Metz, R. Douglas; Nelson, Craig F.

In: Explore: The Journal of Science and Healing, Vol. 6, No. 2, 03.2010, p. 86-99.

Research output: Contribution to journalArticle

Pelletier, Kenneth R ; Herman, Patricia M. ; Metz, R. Douglas ; Nelson, Craig F. / Health and Medical Economics Applied to Integrative Medicine. In: Explore: The Journal of Science and Healing. 2010 ; Vol. 6, No. 2. pp. 86-99.
@article{cb3e89d6372b45768d2f2acea434ad58,
title = "Health and Medical Economics Applied to Integrative Medicine",
abstract = "Cost-benefit analyses (CBA) of every aspect of health and medical care are a necessity to address both the clinical effectiveness and cost effectiveness of health and medical care for the purpose of allocating limited practitioner, organizational, governmental, and monetary resources while maintaining the highest quality outcomes. In response, there are an array of approaches that emphasize the full continuum of prevention, restructuring primary care, involvement of the workplace and communities, and adoption of innovative strategies and interventions ranging from genomic assessments to complementary and alternative medicine (CAM). Among these approaches is an integrative medicine (IM) model that is consistent with these national objectives and that uniquely and explicitly includes {"}evidence-based global medical strategies{"} in its definition. All of these strategies require rigorous, appropriate, state-of-the art medical economic analyses. Since few if any IM models have been rigorously evaluated in terms of CBA, it is possible to draw upon the cost-effectiveness research focused on a limited number of CAM modalities as well as from the work-site/corporate clinical and cost outcomes research to suggest the evidence-based foundation from which a true healthcare system will evolve.",
keywords = "clinical outcomes, complementary and alternative medicine, cost outcomes, evidence based, Integrative medicine, medical economics, Patient Centered Medical Home (PCMH), prevention, primary care",
author = "Pelletier, {Kenneth R} and Herman, {Patricia M.} and Metz, {R. Douglas} and Nelson, {Craig F.}",
year = "2010",
month = "3",
doi = "10.1016/j.explore.2009.12.009",
language = "English (US)",
volume = "6",
pages = "86--99",
journal = "Explore",
issn = "1550-8307",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Health and Medical Economics Applied to Integrative Medicine

AU - Pelletier, Kenneth R

AU - Herman, Patricia M.

AU - Metz, R. Douglas

AU - Nelson, Craig F.

PY - 2010/3

Y1 - 2010/3

N2 - Cost-benefit analyses (CBA) of every aspect of health and medical care are a necessity to address both the clinical effectiveness and cost effectiveness of health and medical care for the purpose of allocating limited practitioner, organizational, governmental, and monetary resources while maintaining the highest quality outcomes. In response, there are an array of approaches that emphasize the full continuum of prevention, restructuring primary care, involvement of the workplace and communities, and adoption of innovative strategies and interventions ranging from genomic assessments to complementary and alternative medicine (CAM). Among these approaches is an integrative medicine (IM) model that is consistent with these national objectives and that uniquely and explicitly includes "evidence-based global medical strategies" in its definition. All of these strategies require rigorous, appropriate, state-of-the art medical economic analyses. Since few if any IM models have been rigorously evaluated in terms of CBA, it is possible to draw upon the cost-effectiveness research focused on a limited number of CAM modalities as well as from the work-site/corporate clinical and cost outcomes research to suggest the evidence-based foundation from which a true healthcare system will evolve.

AB - Cost-benefit analyses (CBA) of every aspect of health and medical care are a necessity to address both the clinical effectiveness and cost effectiveness of health and medical care for the purpose of allocating limited practitioner, organizational, governmental, and monetary resources while maintaining the highest quality outcomes. In response, there are an array of approaches that emphasize the full continuum of prevention, restructuring primary care, involvement of the workplace and communities, and adoption of innovative strategies and interventions ranging from genomic assessments to complementary and alternative medicine (CAM). Among these approaches is an integrative medicine (IM) model that is consistent with these national objectives and that uniquely and explicitly includes "evidence-based global medical strategies" in its definition. All of these strategies require rigorous, appropriate, state-of-the art medical economic analyses. Since few if any IM models have been rigorously evaluated in terms of CBA, it is possible to draw upon the cost-effectiveness research focused on a limited number of CAM modalities as well as from the work-site/corporate clinical and cost outcomes research to suggest the evidence-based foundation from which a true healthcare system will evolve.

KW - clinical outcomes

KW - complementary and alternative medicine

KW - cost outcomes

KW - evidence based

KW - Integrative medicine

KW - medical economics

KW - Patient Centered Medical Home (PCMH)

KW - prevention

KW - primary care

UR - http://www.scopus.com/inward/record.url?scp=77950247634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950247634&partnerID=8YFLogxK

U2 - 10.1016/j.explore.2009.12.009

DO - 10.1016/j.explore.2009.12.009

M3 - Article

VL - 6

SP - 86

EP - 99

JO - Explore

JF - Explore

SN - 1550-8307

IS - 2

ER -